122 related articles for article (PubMed ID: 38550132)
1. Retracted: Pancancer Analysis of Neurovascular-Related NRP Family Genes as Potential Prognostic Biomarkers of Bladder Urothelial Carcinoma.
International BR
Biomed Res Int; 2024; 2024():9802197. PubMed ID: 38550132
[TBL] [Abstract][Full Text] [Related]
2. Pancancer Analysis of Neurovascular-Related NRP Family Genes as Potential Prognostic Biomarkers of Bladder Urothelial Carcinoma.
Deng C; Guo H; Yan D; Liang T; Ye X; Li Z
Biomed Res Int; 2021; 2021():5546612. PubMed ID: 33937395
[TBL] [Abstract][Full Text] [Related]
3. Retracted: Overexpression of miRNA-93-5p Promotes Proliferation and Migration of Bladder Urothelial Carcinoma via Inhibition of KLF9.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9893732. PubMed ID: 37829528
[TBL] [Abstract][Full Text] [Related]
4. Retracted: miR-19a-3p Promotes Tumor-Relevant Behaviors in Bladder Urothelial Carcinoma via Targeting THBS1.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9816712. PubMed ID: 37811256
[TBL] [Abstract][Full Text] [Related]
5. Retracted: Network Pharmacology-Based Study on the Active Component and Mechanism of the Anti-Non-Invasive and Invasive Bladder Urothelial Carcinoma Effects of Zhuling Jisheng Decoction.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9851387. PubMed ID: 37564755
[TBL] [Abstract][Full Text] [Related]
6. Retracted: A Novel Prognostic Stratified System Based on Tumor Budding and the Cell Nest Size in Ureter Urothelial Carcinoma.
And Biomechanics AB
Appl Bionics Biomech; 2023; 2023():9850242. PubMed ID: 37946811
[TBL] [Abstract][Full Text] [Related]
7. Retracted: Identification of Therapeutic Targets and Prognostic Biomarkers among Genes from the Mediator Complex Family in the Hepatocellular Carcinoma Tumour-Immune Microenvironment.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9760920. PubMed ID: 38094413
[TBL] [Abstract][Full Text] [Related]
8. Construction of Protein-related Risk Score Model in Bladder Urothelial Carcinoma.
Luo Q; Zhang X
Biomed Res Int; 2020; 2020():7147824. PubMed ID: 32802870
[TBL] [Abstract][Full Text] [Related]
9. Bladder Tumor Subtype Commitment Occurs in Carcinoma
Wullweber A; Strick R; Lange F; Sikic D; Taubert H; Wach S; Wullich B; Bertz S; Weyerer V; Stoehr R; Breyer J; Burger M; Hartmann A; Strissel PL; Eckstein M
Cancer Res; 2021 Mar; 81(6):1552-1566. PubMed ID: 33472889
[TBL] [Abstract][Full Text] [Related]
10. Identification of Prognostic Immune Genes in Bladder Urothelial Carcinoma.
Su Q; Sun Y; Zhang Z; Yang Z; Qiu Y; Li X; Mo W
Biomed Res Int; 2020; 2020():7510120. PubMed ID: 32420368
[TBL] [Abstract][Full Text] [Related]
11. Retracted: Immunogenomic Landscape Analysis of Prognostic Immune-Related Genes in Hepatocellular Carcinoma.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9764352. PubMed ID: 37860436
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of preoperative hematologic biomarkers in urothelial carcinoma of the bladder treated with radical cystectomy: a systematic review and meta-analysis.
Mori K; Miura N; Mostafaei H; Quhal F; Motlagh RS; Lysenko I; Kimura S; Egawa S; Karakiewicz PI; Shariat SF
Int J Clin Oncol; 2020 Aug; 25(8):1459-1474. PubMed ID: 32451768
[TBL] [Abstract][Full Text] [Related]
13. RB1 and TP53 co-mutations correlate strongly with genomic biomarkers of response to immunity checkpoint inhibitors in urothelial bladder cancer.
Manzano RG; Catalan-Latorre A; Brugarolas A
BMC Cancer; 2021 Apr; 21(1):432. PubMed ID: 33879103
[TBL] [Abstract][Full Text] [Related]
14. LGALS4 as a Prognostic Factor in Urothelial Carcinoma of Bladder Affects Cell Functions.
Ding Y; Cao Q; Wang C; Duan H; Shen H
Technol Cancer Res Treat; 2019 Jan; 18():1533033819876601. PubMed ID: 31558111
[TBL] [Abstract][Full Text] [Related]
15. Retracted: Novel Prognostic Biomarkers for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (CESC) Patients via Analysis of Competing Endogenous RNA (ceRNA) Network.
Markers D
Dis Markers; 2023; 2023():9841329. PubMed ID: 37538089
[TBL] [Abstract][Full Text] [Related]
16. An eight-mRNA signature predicts the prognosis of patients with bladder urothelial carcinoma.
Zhu R; Yang X; Guo W; Xu XJ; Zhu L
PeerJ; 2019; 7():e7836. PubMed ID: 31660264
[TBL] [Abstract][Full Text] [Related]
17. Retracted: LDH and GGT/ALT Ratio as Novel Prognostic Biomarkers in Hepatocellular Carcinoma Patients after Liver Transplantation.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9764203. PubMed ID: 38094457
[TBL] [Abstract][Full Text] [Related]
18. Pancancer Analysis of the Oncogenic and Prognostic Role of
Liu Q; Xie R; Li Y
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077008
[TBL] [Abstract][Full Text] [Related]
19. TROP-2, NECTIN-4 and predictive biomarkers in sarcomatoid and rhabdoid bladder urothelial carcinoma.
Brunelli M; Gobbo S; Malpeli G; Sirgiovanni G; Caserta C; Munari E; Francesconi S; Caliò A; Martignoni G; Cimadamore A; Veccia A; Antonelli A; Tucci M; Pierconti F; Hattab IM; Eccher A; Ascani S; Milella M; Buffoni L; Cheng L; Bracarda S
Pathologica; 2024 Feb; 116(1):55-61. PubMed ID: 38482675
[TBL] [Abstract][Full Text] [Related]
20. Retracted: VEGF Family Gene Expression as Prognostic Biomarkers for Alzheimer's Disease and Primary Liver Cancer.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9893480. PubMed ID: 38094357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
